Related Experiment Videos

Indications for starting or changing disease modifying anti-rheumatic drugs in rheumatoid arthritis patients

G Yanni, E H Choy, G H Kingsley

Clinical and Experimental Rheumatology

|November 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis.

Clinical and experimental immunology·2013

Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy.

Clinical and experimental immunology·2013

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Annals of the rheumatic diseases·2009

Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis.

Clinical and experimental rheumatology·2009

Single photon emission computed tomography and the source of lumbar pain in advanced ankylosing spondylitis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008

A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis.

Annals of the rheumatic diseases·2007

See all related articles